Number of the records: 1
Vorinostat suppresses hypoxia signaling by modulating nuclear translocation of hypoxia inducible factor 1 alpha
Title Vorinostat suppresses hypoxia signaling by modulating nuclear translocation of hypoxia inducible factor 1 alpha Author Zhang Chao Co-authors Yang Ch. Feldman Michael J. Wang Herui Pang Ying Maggio Dominic M. Zhu D. Nesvick Cody L. Dmitriev Pauline Bullová Petra SAVBIOMED ; SAVVIR - Biomedicínske centrum SAV Chittiboina Prashant Brady Roscoe O. Pacak K. Zhuang Z. Source document Oncotarget. Vol. 8, no. 34 (2017), p. 56110-56125 Language eng - English Document kind rozpis článkov z periodík (rbx) Citations GARJE, Rohan - AN, Josiah J. - SANCHEZ, Kevin - GRECO, Austin - STOLWIJK, Jeffrey - DEVOR, Eric - RUSTUM, Youcef - ZAKHARIA, Yousef. Current Landscape and the Potential Role of Hypoxia-Inducible Factors and Selenium in Clear Cell Renal Cell Carcinoma Treatment. In INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. ISSN 1422-0067, 2018, vol. 19, no. 12, pp. KINTING, Susanna - HOEPPNER, Stefanie - SCHINDLBECK, Ulrike - FORSTNER, Maria E. - HARFST, Jacqueline - WITTMANN, Thomas - GRIESE, Matthias. Functional rescue of misfolding ABCA3 mutations by small molecular correctors. In HUMAN MOLECULAR GENETICS. ISSN 0964-6906, 2018, vol. 27, no. 6, pp. 943-953. LI, Yang-ling - ZHANG, Ning-yu - HU, Xiu - CHEN, Jia-ling - RAO, Ming-jun - WU, Lin-wen - LI, Qing-yu - ZHANG, Bo - YAN, Wei - ZHANG, Chong. Evodiamine induces apoptosis and promotes hepatocellular carcinoma cell death induced by vorinostat via downregulating HIF-1 alpha under hypoxia. In BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. ISSN 0006-291X, 2018, vol. 498, no. 3, pp. 481-486. BLEIJS, Margit - VAN DE WETERING, Marc - CLEVERS, Hans - DROST, Jarno. Xenograft and organoid model systems in cancer research. In EMBO JOURNAL. ISSN 0261-4189, 2019, vol. 38, no. 15, pp. DIGIACOMO, Josh W. - GILKES, Daniele M. Therapeutic Strategies to Block the Hypoxic Response. In HYPOXIA AND CANCER METASTASIS. ISSN 0065-2598, 2019, vol. 1136, no., pp. 141-157. KUMANISHI, Shunsuke - YAMANEGI, Koji - NISHIURA, Hiroshi - FUJIHARA, Yuki - KOBAYASHI, Kenta - NAKASHO, Keiji - FUTANI, Hiroyuki - YOSHIYA, Shinichi. Epigenetic modulators hydralazine and sodium valproate act synergistically in VEGI-mediated anti-angiogenesis and VEGF interference in human osteosarcoma and vascular endothelial cells. In INTERNATIONAL JOURNAL OF ONCOLOGY. ISSN 1019-6439, 2019, vol. 55, no. 1, pp. 167-178. ALBADARI, Najah - DENG, Shanshan - LI, Wei. The transcriptional factors HIF-1 and HIF-2 and their novel inhibitors in cancer therapy. In EXPERT OPINION ON DRUG DISCOVERY. ISSN 1746-0441, 2019, vol. 14, no. 7, pp. 667-682. ORTMAYR, Karin - DUBUIS, Sebastien - ZAMPIERI, Mattia. Metabolic profiling of cancer cells reveals genome- wide crosstalk between transcriptional regulators and metabolism. In NATURE COMMUNICATIONS. ISSN 2041-1723, 2019, vol. 10, no., pp. SEMENZA, Gregg L. Pharmacologic Targeting of Hypoxia-Inducible Factors. In ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 59. ISSN 0362-1642, 2019, vol. 59, no., pp. 379-403. EL-SAHLI, S. - WANG, L.S. Cancer Stem Cell-Associated Pathways in the Metabolic Reprogramming of Breast Cancer. In INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. DEC 2020, vol. 21, no. 23. YOUSEF, M.H. - EL-FAWAL, H.A.N. - ABDELNASER, A. Hepigenetics: A Review of Epigenetic Modulators and Potential Therapies in Hepatocellular Carcinoma. In BIOMED RESEARCH INTERNATIONAL. ISSN 2314-6133, NOV 24 2020, vol. 2020. PIERREVELCIN, M. - FUCHS, Q. - LHERMITTE, B. - MESSE, M. - GUERIN, E. - WEINGERTNER, N. - MARTIN, S. - LELONG-REBEL, I. - NAZON, C. - DONTENWILL, M. - ENTZ-WERLE, N. Focus on Hypoxia-Related Pathways in Pediatric Osteosarcomas and Their Druggability. In CELLS. SEP 2020, vol. 9, no. 9. ALBINANA, V. - GALLARDO-VARA, E. - DE ROJAS, I. - RECIO-POVEDA, L. - AGUADO, T. - CANTO-CANO, A. - AGUIRRE, D.T. - SERRA, M.M. - GONZALEZ-PERAMATO, P. - MARTINEZ-PINEIRO, L. - CUESTA, A.M. - BOTELLA, L.M. Targeting beta 2-Adrenergic Receptors Shows Therapeutical Benefits in Clear Cell Renal Cell Carcinoma from Von Hippel-Lindau Disease. In JOURNAL OF CLINICAL MEDICINE. SEP 2020, vol. 9, no. 9. LIAO, C.H. - ZHANG, Q. ASIP COTRAN EARLY CAREER INVESTIGATOR AWARD LECTURE Understanding the Oxygen-Sensing Pathway and Its Therapeutic Implications in Diseases. In AMERICAN JOURNAL OF PATHOLOGY. ISSN 0002-9440, AUG 2020, vol. 190, no. 8, p. 1584-1595. COX, D.J. - COLEMAN, A.M. - GOGAN, K.M. - PHELAN, J.J. - MAOLDOMHNAIGH, C.O. - DUNNE, P.J. - BASDEO, S.A. - KEANE, J. Inhibiting Histone Deacetylases in Human Macrophages Promotes Glycolysis, IL-1 beta, and T Helper Cell Responses toMycobacterium tuberculosis. In FRONTIERS IN IMMUNOLOGY. ISSN 1664-3224, JUL 23 2020, vol. 11. NOURI-VASKEH, M. - ALIZADEH, L. - HAJIASGHARZADEH, K. - MOKHTARZADEH, A. - HALIMI, M. - BARADARAN, B. The role of HSP90 molecular chaperones in hepatocellular carcinoma. In JOURNAL OF CELLULAR PHYSIOLOGY. ISSN 0021-9541, DEC 2020, vol. 235, no. 12, p. 9110-9120. CERVELLO, M. - EMMA, M.R. - AUGELLO, G. - CUSIMANO, A. - GIANNITRAPANI, L. - SORESI, M. - AKULA, S.M. - ABRAMS, S.L. - STEELMAN, L.S. - GULINO, A. - BELMONTE, B. - MONTALTO, G. - MCCUBREY, J.A. New landscapes and horizons in hepatocellular carcinoma therapy. In AGING-US. ISSN 1945-4589, FEB 15 2020, vol. 12, no. 3, p. 3053-3094. HAIT, N.C. - MAITI, A. - XU, P. - QI, Q.Y. - KAWAGUCHI, T. - OKANO, M. - TAKABE, K. - YAN, L. - LUO, C. Regulation of hypoxia-inducible factor functions in the nucleus by sphingosine-1-phosphate. In FASEB JOURNAL. ISSN 0892-6638, MAR 2020, vol. 34, no. 3, p. 4293-4310. COLLIER, C.D. - GETTY, P.J. - GREENFIELD, E.M. Targeting the Cancer Epigenome with Histone Deacetylase Inhibitors in Osteosarcoma. In CURRENT ADVANCES IN THE SCIENCE OF OSTEOSARCOMA: RESEARCH PERSPECTIVES: TUMOR BIOLOGY, ORGAN MICROENVIRONMENT, POTENTIAL NEW THERAPEUTIC TARGETS, AND CANINE MODELS, 2ND EDITION. ISSN 0065-2598, 2020, vol. 1258, p. 55-75. GUO, Y. - XIAO, Z.Q. - YANG, L. - GAO, Y.L. - ZHU, Q.J. - HU, L.J. - HUANG, D.S. - XU, Q.R. Hypoxia-inducible factors in hepatocellular carcinoma. In ONCOLOGY REPORTS. ISSN 1021-335X, JAN 2020, vol. 43, no. 1, p. 3-15. PATRA, S. - PRAHARAJ, P.P. - KLIONSKY, D.J. - BHUTIA, S.K. Vorinostat in autophagic cell death: A critical insight into autophagy-mediated,-associated and -dependent cell death for cancer prevention. In DRUG DISCOVERY TODAY. ISSN 1359-6446, JAN 2022, vol. 27, no. 1, p. 269-279. ZENG, Z. - LAN, T.X. - WEI, Y.Q. - WEI, X.W. CCL5/CCR5 axis in human diseases and related treatments. In GENES & DISEASES. ISSN 2352-4820, JAN 2022, vol. 9, no. 1, p. 12-27. KOPECKA, J. - SALAROGLIO, I.C. - PEREZ-RUIZ, E. - SARMENTO-RIBEIRO, A.B. - SAPONARA, S. - DE LAS RIVAS, J. - RIGANTI, C. Hypoxia as a driver of resistance to immunotherapy. In DRUG RESISTANCE UPDATES. ISSN 1368-7646, DEC 2021, vol. 59. SEEBACHER, N.A. - KRCHNIAKOVA, M. - STACY, A.E. - SKODA, J. - JANSSON, P.J. Tumour Microenvironment Stress Promotes the Development of Drug Resistance. In ANTIOXIDANTS. NOV 2021, vol. 10, no. 11. PIPALIA, N.H. - SAAD, S.Z. - SUBRAMANIAN, K. - CROSS, A. - AL-MOTAWA, A. - GARG, K. - BLAGG, B.S.J. - NECKERS, L. - HELQUIST, P. - WIEST, O. - ORY, D.S. - MAXFIELD, F.R. HSP90 inhibitors reduce cholesterol storage in Niemann-Pick type C1 mutant fibroblasts. In JOURNAL OF LIPID RESEARCH. ISSN 0022-2275, 2021, vol. 62. TORRES, H.M. - VANCLEAVE, A.M. - VOLLMER, M. - CALLAHAN, D.L. - SMITHBACK, A. - CONN, J.M. - RODEZNO-ANTUNES, T. - GAO, Z.L. - CAO, Y.X. - AFEWORKI, Y. - TAO, J.N. Selective Targeting of Class I Histone Deacetylases in a Model of Human Osteosarcoma. In CANCERS. AUG 2021, vol. 13, no. 16. ANCEL, J. - PEROTIN, J.M. - DEWOLF, M. - LAUNOIS, C. - MULETTE, P. - NAWROCKI-RABY, B. - DALSTEIN, V. - GILLES, C. - DESLEE, G. - POLETTE, M. - DORMOY, V. Hypoxia in Lung Cancer Management: A Translational Approach. In CANCERS. JUL 2021, vol. 13, no. 14. TELAROVIC, I. - WENGER, R.H. - PRUSCHY, M. Interfering with Tumor Hypoxia for Radiotherapy Optimization. In JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. JUN 21 2021, vol. 40, no. 1. SERWETNYK, M.A. - BLAGG, B.S.J. The disruption of protein-protein interactions with co-chaperones and client substrates as a strategy towards Hsp90 inhibition. In ACTA PHARMACEUTICA SINICA B. ISSN 2211-3835, JUN 2021, vol. 11, no. 6, p. 1446-1468. SHIRAI, Y. - CHOW, C.C.T. - KAMBE, G. - SUWA, T. - KOBAYASHI, M. - TAKAHASHI, I. - HARADA, H. - NAM, J.M. An Overview of the Recent Development of Anticancer Agents Targeting the HIF-1 Transcription Factor. In CANCERS. JUN 2021, vol. 13, no. 11. ISLAM, M.R. - LBIK, D. - SAKIB, M.S. - HOFMANN, R.M. - BERULAVA, T. - MAUSBACH, M.J. - CHA, J. - GOLDBERG, M. - VAKHTANG, E. - SCHIFFMANN, C. - ZIESENISS, A. - KATSCHINSKI, D.M. - SANANBENESI, F. - TOISCHER, K. - FISCHER, A. Epigenetic gene expression links heart failure to memory impairment. In EMBO MOLECULAR MEDICINE. ISSN 1757-4676, MAR 5 2021, vol. 13, no. 3. SCHONBERGER, T. - FANDREY, J. - PROST-FINGERLE, K. Ways into Understanding HIF Inhibition. In CANCERS. JAN 2021, vol. 13, no. 1. Category ADMA - Scientific papers in foreign impacted journals registered in Web of Sciences or Scopus Category of document (from 2022) V3 - Vedecký výstup publikačnej činnosti z časopisu Type of document článok Year 2017 Registered in WOS Registered in SCOPUS DOI 10.18632/oncotarget.18125 
article
rok CC IF IF Q (best) JCR Av Jour IF Perc SJR SJR Q (best) CiteScore N rok vydania rok metriky IF IF Q (best) SJR SJR Q (best) 2017 2016 5.168 Q1 1.994 Q1
Number of the records: 1